Cargando…
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial
Despite the progress that has been made in other forms of cancer therapy, Provenge® (Sipuleucel-T) is the only FDA-approved vaccine for the treatment of cancer. To understand the current landscape of therapeutic oncology vaccines we performed a quantitative analysis of phase 2 and phase 3 therapeuti...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647658/ https://www.ncbi.nlm.nih.gov/pubmed/26579225 http://dx.doi.org/10.1186/s40425-015-0093-x |